PATENT CLAIM ANALYSIS

Application Number: 15984747
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "259300"]

Abstract:
Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Claim (Index 10):
A compound selected from the group consisting of 1-18 below: or a pharmaceutically acceptable salt or stereoisomer thereof.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13099179', '12813142', '13382145', '15139164', '13004808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8032101521425548
- 35 USC 102 Novelty (BERT): 0.5392399668019373
- Combined Prediction Score: 0.776813133608493
- Mean Citation Score: 356.240646
- Max Citation Score: 370.0746
- Similarity Product: 267.60617348034384

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test